Stable freeze-dried pharmaceutical formulation
US6284277A · kind A · utility
34Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 1998 |
| Grant date | Sep 4, 2001 |
| Priority date | — |
| Expiry date | Dec 9, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject of the invention is a freeze-dried formulation consisting of an amorphous phase and a crystalline phase, which is pharmaceutically acceptable, comprising at least one nonprotein active ingredient, characterized in that it contains mannitol and alanine in a ratio R of between 0.1 and 1, R representing the mass of mannitol to the mass of alanine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.